Paper38947228
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report.
Leger KJ and 14 others. Front Cardiovasc Med, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report. Papers, record 38947228. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38947228
- Disease
- acute myeloid leukemia587 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K24 HL167127 | NHLBI NIH HHS | United States | K24HL167127 | PubMed and NIH | NIH RePORTER |
| K23 HL163456 | NHLBI NIH HHS | United States | K23HL163456 | PubMed | NIH RePORTER |
| K01 HL143153 | NHLBI NIH HHS | United States | K01HL143153 | PubMed and NIH | NIH RePORTER |
| U10 CA180899 | NCI NIH HHS | United States | U10CA180899 | PubMed and NIH | NIH RePORTER |
| U10 CA180886 | NCI NIH HHS | United States | U10CA180886 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04293562 | A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations | Derived from the trial | Yes |
Source ClinicalTrials.gov
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21298750 | Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United Kingdom. | Pediatr Blood Cancer | 2011 | https://conductscience.org/library/papers/21298750 | PubMed |
| 2 | 17054231 | Different anthracycline derivates for reducing cardiotoxicity in cancer patients. | Cochrane Database Syst Rev | 2006 | https://conductscience.org/library/papers/17054231 | PubMed |
| 3 | 16375591 | N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability. | Clin Chem Lab Med | 2006 | https://conductscience.org/library/papers/16375591 | PubMed |
| 4 | 3411343 | Doxorubicin clearance in the obese. | J Clin Oncol | 1988 | https://conductscience.org/library/papers/3411343 | PubMed |
| 5 | 35277733 | Age-Dependent Reference Values for hs-Troponin T and NT-proBNP and Determining Factors in a Cohort of Healthy Children (The LIFE Child Study). | Pediatr Cardiol | 2022 | https://conductscience.org/library/papers/35277733 | PubMed |
| 6 | 32466789 | Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure. | BMC Pharmacol Toxicol | 2020 | https://conductscience.org/library/papers/32466789 | PubMed |
| 7 | 8993985 | Reproducibility of left ventricular size, shape and mass with echocardiography, magnetic resonance imaging and radionuclide angiography in patients with anterior wall infarction. A plea for core laboratories. | Int J Card Imaging | 1996 | https://conductscience.org/library/papers/8993985 | PubMed |
| 8 | 37397086 | Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer. | JACC CardioOncol | 2023 | https://conductscience.org/library/papers/37397086 | PubMed |
| 9 | 12413441 | Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction. | Eur J Echocardiogr | 2002 | https://conductscience.org/library/papers/12413441 | PubMed |
| 10 | 30379624 | Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group. | J Clin Oncol | 2019 | https://conductscience.org/library/papers/30379624 | PubMed |
| 11 | 27206819 | 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. | Eur Heart J | 2016 | https://conductscience.org/library/papers/27206819 | PubMed |
| 12 | 31351792 | Challenges With Left Ventricular Functional Parameters: The Pediatric Heart Network Normal Echocardiogram Database. | J Am Soc Echocardiogr | 2019 | https://conductscience.org/library/papers/31351792 | PubMed |
| 13 | 27708836 | Pathophysiology of sepsis-induced myocardial dysfunction. | Mil Med Res | 2016 | https://conductscience.org/library/papers/27708836 | PubMed |
| 14 | 30024784 | CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/30024784 | PubMed |
| 15 | 29966479 | Congestive heart failure among children with acute leukemia: a population-based matched cohort study. | Leuk Lymphoma | 2019 | https://conductscience.org/library/papers/29966479 | PubMed |
| 16 | 23319696 | Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23319696 | PubMed |
| 17 | 27085442 | Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction. | JACC Cardiovasc Imaging | 2016 | https://conductscience.org/library/papers/27085442 | PubMed |
| 18 | 23697708 | Fat and lean BMI reference curves in children and adolescents and their utility in identifying excess adiposity compared with BMI and percentage body fat. | Am J Clin Nutr | 2013 | https://conductscience.org/library/papers/23697708 | PubMed |
| 19 | 25616572 | Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. program. | Haematologica | 2015 | https://conductscience.org/library/papers/25616572 | PubMed |
| 20 | 7760889 | Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. | N Engl J Med | 1995 | https://conductscience.org/library/papers/7760889 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41594244 | Pediatric Cardio-Oncology: From Gap in Evidence to Future Perspectives. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41594244 | PubMed |
| 41118594 | CPX-351 in Down syndrome-associated myeloid leukemia: results and prognostic factors from the phase 3 ML-DS 2018 trial. | Blood | 2026 | https://conductscience.org/library/papers/41118594 | PubMed |
| 41096539 | A Novel Approach to Prognostic Factors and Risk Stratification in Pediatric AML: Case Report and Literature Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096539 | PubMed |
| 40815417 | Safety of liposomal daunorubicin-cytarabine (CPX-351) in secondary AML: Japanese phase 1/2 study and global phase 3 study. | Int J Hematol | 2025 | https://conductscience.org/library/papers/40815417 | PubMed |
| 40778417 | Precision oncology to overcome resistance in R/R AML in children and adults requires combinations of cytotoxic, targeted, and immunological treatments. | J Intern Med | 2025 | https://conductscience.org/library/papers/40778417 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TNNT2 | 7139 | PubTator's text mining | https://conductscience.org/library/genes/7139 |
Source NCBI Gene
Drugs9
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| DEXRAZOXANE HYDROCHLORIDE | CHEMBL1200778 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1200778 | ChEMBL |
| GEMTUZUMAB OZOGAMICIN | CHEMBL1201506 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1201506 | ChEMBL |
| MITOXANTRONE HYDROCHLORIDE | CHEMBL1417019 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1417019 | ChEMBL |
| DAUNORUBICIN HYDROCHLORIDE | CHEMBL1563 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1563 | ChEMBL |
| ASPARAGINASE ERWINIA CHRYSANTHEMI | CHEMBL1863514 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1863514 | ChEMBL |
| GILTERITINIB | CHEMBL3301622 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL3301622 | ChEMBL |
| METHOTREXATE | CHEMBL34259 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL34259 | ChEMBL |
| ETOPOSIDE | CHEMBL44657 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL44657 | ChEMBL |
| CYTARABINE | CHEMBL803 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL803 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38947228
GET https://conductscience.org/api/papers/v1/38947228/references?page=2